» Articles » PMID: 1502155

Intracellular Accumulation and Resistance to Degradation of the Alzheimer Amyloid A4/beta Protein

Overview
Specialty Science
Date 1992 Aug 15
PMID 1502155
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

The A4 or beta protein is a peptide that constitutes the major protein component of senile plaques in Alzheimer disease. The A4/beta protein is derived from a larger, transmembrane amyloid precursor protein (APP). The putative abnormal processing events leading to amyloid accumulation are largely unknown. Here we report that a 42-residue synthetic peptide, beta 1-42, corresponding to one of the longer forms of the A4/beta protein, accumulates in cultured human skin fibroblasts and is stable for at least 3 days. The peptide appears to accumulate intracellularly, since it does not accumulate under conditions that prevent endocytosis and accumulation is correlated with the acquisition of resistance to removal by trypsin digestion. This intracellular accumulation is also correlated with the ability of the peptide to aggregate as determined by SDS/polyacrylamide gel electrophoresis. At low concentrations of the beta 1-42 peptide, which favor the nonaggregated state, no accumulation is observed. Shorter peptide analogs (28 or 39 residues) that are truncated at the C terminus, which lack the ability to aggregate in SDS gels, fail to accumulate. The accumulated intracellular beta 1-42 peptide is in an aggregated state and is contained in a dense organellar compartment that overlaps the distribution of late endosomes or secondary lysosomes. Immunofluorescence of the internalized peptide in permeabilized cells reveals that it is contained in granular deposits, consistent with localization in late endosomes or secondary lysosomes. Sequence analysis indicates that some of the internalized peptide is subject to N-terminal trimming. These results suggest that the aggregated A4/beta protein may be resistant to degradation and suggest that the A4/beta protein may arise, at least in part, by endosomal or lysosomal processing of APP. Our results also suggest that relatively nonspecific proteolysis may be sufficient to generate the A4/beta protein if this part of APP is selectively resistant to proteolysis.

Citing Articles

The Relevance and Implications of Monoclonal Antibody Therapies on Traumatic Brain Injury Pathologies.

Wang P, Okada-Rising S, Scultetus A, Bailey Z Biomedicines. 2025; 12(12.

PMID: 39767605 PMC: 11672875. DOI: 10.3390/biomedicines12122698.


APOE from astrocytes restores Alzheimer's Aβ-pathology and DAM-like responses in APOE deficient microglia.

Preman P, Moechars D, Fertan E, Wolfs L, Serneels L, Shah D EMBO Mol Med. 2024; 16(12):3113-3141.

PMID: 39528861 PMC: 11628604. DOI: 10.1038/s44321-024-00162-7.


The Multifaceted Role of WNT Signaling in Alzheimer's Disease Onset and Age-Related Progression.

Kostes W, Brafman D Cells. 2023; 12(8).

PMID: 37190113 PMC: 10136584. DOI: 10.3390/cells12081204.


In Situ Assembly of Platinum(II)-Metallopeptide Nanostructures Disrupts Energy Homeostasis and Cellular Metabolism.

Zhou Z, Maxeiner K, Moscariello P, Xiang S, Wu Y, Ren Y J Am Chem Soc. 2022; 144(27):12219-12228.

PMID: 35729777 PMC: 9284552. DOI: 10.1021/jacs.2c03215.


Neurodegenerative Proteinopathies in the Proteoform Spectrum-Tools and Challenges.

Noor A, Zafar S, Zerr I Int J Mol Sci. 2021; 22(3).

PMID: 33499319 PMC: 7865347. DOI: 10.3390/ijms22031085.


References
1.
Cabral L, Unger W, Boulton M, Marshall J . A microsystem to assay lysosomal enzyme activities in cultured retinal pigment epithelial cells. Curr Eye Res. 1988; 7(11):1097-104. DOI: 10.3109/02713688809001880. View

2.
McKinley D, Wiley H . Reassessment of fluid-phase endocytosis and diacytosis in monolayer cultures of human fibroblasts. J Cell Physiol. 1988; 136(3):389-97. DOI: 10.1002/jcp.1041360302. View

3.
Wiley H, Cunningham D . Epidermal growth factor stimulates fluid phase endocytosis in human fibroblasts through a signal generated at the cell surface. J Cell Biochem. 1982; 19(4):383-94. DOI: 10.1002/jcb.240190407. View

4.
Cataldo A, Nixon R . Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci U S A. 1990; 87(10):3861-5. PMC: 54003. DOI: 10.1073/pnas.87.10.3861. View

5.
Estus S, Golde T, Kunishita T, Blades D, Lowery D, Eisen M . Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science. 1992; 255(5045):726-8. DOI: 10.1126/science.1738846. View